![](/img/cover-not-exists.png)
Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer
Leprieur, Etienne Giroux, Herbretau, Guillaume, Dumenil, Coraline, Julie, Catherine, Giraud, Violaine, Labrune, Sylvie, Dumoulin, Jennifer, Tisserand, Julie, Emile, Jean-François, Blons, Hélène, ChineLanguage:
english
Journal:
OncoImmunology
DOI:
10.1080/2162402X.2018.1424675
Date:
January, 2018
File:
PDF, 2.72 MB
english, 2018